Institute of Biomedicine - News

The new textbook came in handy for students taking Professor Carsten Carlberg’s lecture course “Molecular Medicine and Genetics” this autumn.

Selected to the Academy of Finland’s Flagship Programme for the years 2020–2024, the GeneCellNano Flagship seeks to speed up the introduction of new biological drugs for severe chronic diseases. The Flagship is led by Academy Professor Seppo Ylä-Herttuala.

A new study sheds light on the role of diabetes in the cellular and molecular changes underlying Alzheimer's disease (AD).

Individualised and family-based physical activity and dietary counselling considerably slows down the development of insulin resistance.

New sensitive and effective proteomics methods can be applied to identify potential novel drug targets in inflammatory conditions, leukemia and prostate cancer, according to the doctoral dissertation of Joanna Lempiäinen, MSc.

A new study conducted by researchers at the University of Eastern Finland found that the PLCG2-P522R genetic variant, which protects against Alzheimer’s disease, enhances several key functions of immune cells.